Efficacy and Safety Study of Topical Rapamycin Associated With Pulsed Dye Laser in Patients With Sturge-Weber Syndrome

Key facts

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra

Principal Investigator

Maider Pretel, MD PhD

Clinica Universidad de Navarra

Intervention

Drug: Topical Rapamycin(drug)

Enrollment

23 enrolled

Eligibility

16-65 years · All sexes

Timeline

2011 – 2012

Study locations (1)

• Clinica Universidad de Navarra, Pamplona, Navarre, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Sturge-Weber syndrome

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT04717427
  Longitudinal Studies to Identify Biomarkers for Sturge-Weber Syndrome
  University of Illinois at Chicago
• ACTIVE NOT RECRUITINGNANCT04517565
  Longitudinal Neuroimaging in Sturge-Weber Syndrome
  Wayne State University
• ACTIVE NOT RECRUITINGNCT01425944
  Innovative Approaches to Gauge Progression of Sturge-Weber Syndrome
  Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

See all trials for Sturge-Weber syndrome →